Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2025 Filed Mar 13, 2025 21:26 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 7,324 $26.34 $192,914.16
Disclosure

SEC source: 0001628280-25-012680 · wk-form4_1741901179.xml · nonDerivative · entry 2

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,492

F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 21:26 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 1,577 $25.00 $39,425.00
Disclosure

SEC source: 0001628280-25-012681 · wk-form4_1741901189.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,961

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 21:26 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 1,091 $25.00 $27,275.00
Disclosure

SEC source: 0001628280-25-012680 · wk-form4_1741901179.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,816

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 21:26 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 1,597 $25.00 $39,925.00
Disclosure

SEC source: 0001628280-25-012679 · wk-form4_1741901168.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,601

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 21:26 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 1,331 $25.00 $33,275.00
Disclosure

SEC source: 0001628280-25-012678 · wk-form4_1741901158.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,912

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 21:25 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 4,151 $25.00 $103,775.00
Disclosure

SEC source: 0001628280-25-012677 · wk-form4_1741901146.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,809

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 22:14 UTC
Werner SeanChief Technology Officer
SaleCommon Stock 88 $24.03 $2,114.64
Disclosure

SEC source: 0001628280-25-010568 · wk-form4_1741212833.xml · nonDerivative · entry 2

Werner Sean · CIK 0002047541 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,865

F2 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-01-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:13 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 324 $25.46 $8,249.04
Disclosure

SEC source: 0001628280-25-010566 · wk-form4_1741212823.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,243

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:14 UTC
Werner SeanChief Technology Officer
SaleCommon Stock 136 $25.46 $3,462.56
Disclosure

SEC source: 0001628280-25-010568 · wk-form4_1741212833.xml · nonDerivative · entry 1

Werner Sean · CIK 0002047541 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,953

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:13 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 425 $25.46 $10,820.50
Disclosure

SEC source: 0001628280-25-010565 · wk-form4_1741212812.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 262,198

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:13 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 284 $25.46 $7,230.64
Disclosure

SEC source: 0001628280-25-010563 · wk-form4_1741212791.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,907

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:13 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 660 $25.46 $16,803.60
Disclosure

SEC source: 0001628280-25-010564 · wk-form4_1741212802.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,960

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:13 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 424 $25.46 $10,795.04
Disclosure

SEC source: 0001628280-25-010562 · wk-form4_1741212781.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,538

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:47 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 92 $26.54 $2,441.68
Disclosure

SEC source: 0001628280-25-005844 · wk-form4_1739573226.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 262,623

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:46 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 78 $26.54 $2,070.12
Disclosure

SEC source: 0001628280-25-005842 · wk-form4_1739573206.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,567

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:47 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 159 $26.54 $4,219.86
Disclosure

SEC source: 0001628280-25-005843 · wk-form4_1739573216.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,620

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:46 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 102 $26.54 $2,707.08
Disclosure

SEC source: 0001628280-25-005840 · wk-form4_1739573194.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,962

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:46 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 53 $26.54 $1,406.62
Disclosure

SEC source: 0001628280-25-005839 · wk-form4_1739573185.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,191

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 00:11 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 240 $27.02 $6,484.80
Disclosure

SEC source: 0001628280-25-000987 · wk-form4_1736381469.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,244

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 00:11 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 404 $27.02 $10,916.08
Disclosure

SEC source: 0001628280-25-000986 · wk-form4_1736381459.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 262,715

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 00:10 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 343 $27.02 $9,267.86
Disclosure

SEC source: 0001628280-25-000985 · wk-form4_1736381449.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,064

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 00:10 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 328 $27.02 $8,862.56
Disclosure

SEC source: 0001628280-25-000983 · wk-form4_1736381429.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,645

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
January 06, 2025 Filed Jan 9, 2025 00:10 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 987 $27.02 $26,668.74
Disclosure

SEC source: 0001628280-25-000982 · wk-form4_1736381417.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,779

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
December 17, 2024 Filed Dec 19, 2024 22:19 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 13,196 $27.16 $358,403.36
Disclosure

SEC source: 0001628280-24-052104 · wk-form4_1734646743.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 263,119

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 6-14-2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.62 to $27.48, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 16, 2024 Filed Dec 19, 2024 22:19 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 7,604 $27.33 $207,817.32
Disclosure

SEC source: 0001628280-24-052104 · wk-form4_1734646743.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 276,315

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 6-14-2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.88 to $28.33, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 26, 2024 Filed Nov 29, 2024 22:30 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 581 $27.20 $15,803.20
Disclosure

SEC source: 0001628280-24-049480 · wk-form4_1732919407.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,766

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 26, 2024 Filed Nov 29, 2024 22:30 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 523 $27.20 $14,225.60
Disclosure

SEC source: 0001628280-24-049479 · wk-form4_1732919397.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 283,919

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 26, 2024 Filed Nov 29, 2024 22:29 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 349 $27.20 $9,492.80
Disclosure

SEC source: 0001628280-24-049478 · wk-form4_1732919386.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,407

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 26, 2024 Filed Nov 29, 2024 22:29 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 216 $27.20 $5,875.20
Disclosure

SEC source: 0001628280-24-049477 · wk-form4_1732919376.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,484

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 26, 2024 Filed Nov 29, 2024 22:29 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 252 $27.20 $6,854.40
Disclosure

SEC source: 0001628280-24-049476 · wk-form4_1732919366.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,973

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 18, 2024 Filed Nov 19, 2024 22:32 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 17,604 $20.05 $352,960.20
Disclosure

SEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284,442

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 22:32 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 22:32 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 15,000 $21.17 $317,550.00
Disclosure

SEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 302,046

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.79 to $21.68, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 22:32 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $21.16 $211,600.00
Disclosure

SEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,046

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.82 to $21.68, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 15, 2024 Filed Nov 19, 2024 22:32 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-24-048542 · wk-form4_1732055527.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 327,046

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2024 Filed Nov 14, 2024 23:38 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 91 $26.34 $2,396.94
Disclosure

SEC source: 0001628280-24-047995 · wk-form4_1731627486.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,756

F1 · shares: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 12, 2024 Filed Nov 14, 2024 23:38 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 66 $26.34 $1,738.44
Disclosure

SEC source: 0001628280-24-047994 · wk-form4_1731627476.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,225

F1 · shares: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 12, 2024 Filed Nov 14, 2024 23:37 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 123 $26.34 $3,239.82
Disclosure

SEC source: 0001628280-24-047993 · wk-form4_1731627466.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,046

F1 · shares: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
November 12, 2024 Filed Nov 14, 2024 23:37 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 147 $26.19 $3,849.93
Disclosure

SEC source: 0001628280-24-047992 · wk-form4_1731627455.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,347

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 08-09-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 31, 2024 Filed Jan 9, 2025 00:10 UTC
DE GREEF RODERICKDirector · President and CEO
SaleCommon Stock 46,896 $23.43 $1,098,773.28
Disclosure

SEC source: 0001628280-25-000984 · wk-form4_1736381439.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 414,958

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 10-19-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 23:02 UTC
Aebersold SarahChief Human Resources Officer
SaleCommon Stock 203 $23.15 $4,699.45
Disclosure

SEC source: 0001628280-24-044815 · wk-form4_1730502121.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,700

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 23:01 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 311 $23.15 $7,199.65
Disclosure

SEC source: 0001628280-24-044814 · wk-form4_1730502110.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,847

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 23:01 UTC
Foster Karen A.Chief Quality and Operations
SaleCommon Stock 277 $23.15 $6,412.55
Disclosure

SEC source: 0001628280-24-044813 · wk-form4_1730502101.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,291

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-23 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 23:01 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 547 $23.15 $12,663.05
Disclosure

SEC source: 0001628280-24-044812 · wk-form4_1730502090.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,169

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 30, 2024 Filed Nov 1, 2024 23:01 UTC
Wichterman TroyChief Financial Officer
SaleCommon Stock 894 $23.15 $20,696.10
Disclosure

SEC source: 0001628280-24-044811 · wk-form4_1730502079.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,494

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 22:25 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 22:25 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $23.17 $231,700.00
Disclosure

SEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,716

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.90 to $23.53, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 22:25 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $2.06 $20,600.00
Disclosure

SEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 327,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 22:25 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $2.06 $0.00
Disclosure

SEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2025-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 22:25 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $23.28 $232,800.00
Disclosure

SEC source: 0001628280-24-043067 · wk-form4_1729203937.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,716

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 06-14-2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.49, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.